By Siddhi Mahatole and Sriparna Roy

(Reuters) -The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals’ drug to manage pain related to a type of chronic condition called fibromyalgia, the company said on Friday.

The approval paves the way for the drug to be the first new treatment option in over 15 years for patients with fibromyalgia, which causes widespread pain, fatigue as well as problems with sleep and memory.

Patients have so far relied on older drugs such as Lyrica, Cymbalta and AbbVie’s Savella.

The non-opioid drug, which will be sold under the brand name Tonmya, is a pill designed for bedtime treatment to improve sleep quality and reduce pain associated with the chronic condition.

“This is the first time that a drug has been developed to target the non-restor

See Full Page